Grace Therapeutics, Inc. (GRCE) — Free Cash Flow Generation Index
Latest as of December 2012:
0.41x
Grace Therapeutics, Inc. (GRCE) has a Free Cash Flow Generation Index of 0.41x as of December 2012. Free cash flow of $55.73K represents 0% of operating cash flow ($136.29K). Explore capital reinvestment ratio of Grace Therapeutics, Inc. to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.41x
Free Cash Flow / Operating CF
Free Cash Flow
$55.73K
USD
Operating Cash Flow
$136.29K
USD
Capital Expenditures
$80.55K
USD
Annual Free Cash Flow Generation for Grace Therapeutics, Inc. (None–None)
Year-by-year Free Cash Flow Generation Index for Grace Therapeutics, Inc.. Check how aggressively does Grace Therapeutics, Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).